These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

85 related items for PubMed ID: 5821450

  • 1. [The importance of magnesium in preventing myocardial metabolic disorders in thyrotoxicosis].
    Golber LM, Anan'eva KA, Kandror VI, Kriukova IV, Negovskaia AV.
    Biull Eksp Biol Med; 1969 Mar; 67(3):23-6. PubMed ID: 5821450
    [No Abstract] [Full Text] [Related]

  • 2. [Content of the adenylic system components and glycogen in the myocaridium in circulatory disorders].
    Nechyporenko ZIu, Gimmel'reĭkh NH, Goloborod'ko OP.
    Ukr Biokhim Zh; 1965 Mar; 37(3):352-9. PubMed ID: 5878077
    [No Abstract] [Full Text] [Related]

  • 3. [Problems of experimental prophylaxis of metabolic disorders of the myocardium in thyrotoxicosis].
    Gol'ber LM, Kandror VI, Dagaeva LN.
    Patol Fiziol Eksp Ter; 1966 Mar; 10(3):16-20. PubMed ID: 5239866
    [No Abstract] [Full Text] [Related]

  • 4. [The antithyrotropic effect of magnesium ions].
    Rachev R, Milanov S, Papazov G, Filipova E, Dashev G.
    Eksp Med Morfol; 1972 Mar; 11(1):1-5. PubMed ID: 4143123
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Experimental lesions of the myocardium: role of alterations of energetic metabolism].
    Anichkov SV, Zavodskaya IS, Moreva EV.
    Clin Ter; 1981 Sep 15; 98(5):473-80. PubMed ID: 6273056
    [No Abstract] [Full Text] [Related]

  • 8. [Cardiac involvement in thyrotoxicosis and aging. Sphygmographic study].
    Felt V, Cenková V.
    Cas Lek Cesk; 1983 Apr 29; 122(17):522-5. PubMed ID: 6850725
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Tissue cobalt content in "beer drinkers' myocardiopathy".
    Sullivan J, Parker M, Carson SB.
    J Lab Clin Med; 1968 Jun 29; 71(6):893-911. PubMed ID: 5654775
    [No Abstract] [Full Text] [Related]

  • 11. [Hyperthyroidism with destructive myocardial changes observed by means of endomyocardial biopsy. Report of a case].
    Morimoto S, Matsumura K, Osamura Y, Harada M, Komatsu Y, Sekiguchi M.
    Kokyu To Junkan; 1982 Sep 29; 30(9):953-8. PubMed ID: 7178699
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Role of electrolytes in prevention and therapy of experimental cardiomyopathies.
    Bajusz E.
    Recent Adv Stud Cardiac Struct Metab; 1973 Sep 29; 2():815. PubMed ID: 4807001
    [No Abstract] [Full Text] [Related]

  • 15. Heart damage in thyrotoxicosis and implication of ischemic disease of the heart - questions about pathogenesis, diagnosis and treatment.
    Felt V.
    Czech Med; 1983 Sep 29; 6(3):175-7. PubMed ID: 6416795
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Myocardial high energy phosphate stores in cardiac hypertrophy and heart failure.
    Pool PE, Spann JF, Buccino RA, Sonnenblick EH, Braunwald E.
    Circ Res; 1967 Sep 29; 21(3):365-73. PubMed ID: 6061642
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.